-
BSEM share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Price change
The price of BSEM shares has decreased $0.06 since the market last closed. This is a 1.57% drop.
-
Opened at $3.82.
The stock opened $0.01 higher than its previous close.
Key terms
About BSEM
BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. It offers pre-treatment assessment, cell therapies, anti-aging, and wellness compounds. The company was founded by Andrew Smith Van Vurst, Henry W. Van Vurst IV, and Jason Matuszewski on April 29, 1939 and is headquartered in Pompano Beach, FL.
-
Market cap: $67.94M
A market capitalization up to $300 million places BSEM in the micro-capitalization category.
Key terms
Smart score
Latest BSEM news
BSEM Financials
-
Total revenue: $47.48M (1Y), $7.90M (Q2)
Total Revenue decreased 84.27% since last year and increased 28.75% since last quarter.
-
Net income: -$6.58M (1Y), -$8.97M (Q2)
Net Income decreased 120.64% since last year and increased 1.72% since last quarter.
-
Earnings per share: -$0.39 (1Y), -$0.52 (Q2)
EPS decreased 126.77% since last year and increased 1.07% since last quarter.
Key terms
BSEM Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
BSEM Competitors
-
How competitors are chosen
BSEM's competitors are included in the Health Technology sector and Biotechnology group
-
Market cap: $67.94M
A market capitalization up to $300 million places BSEM in the micro-capitalization category.
Key terms
Latest investing news
-
Bond market takes a breather after surprise move by Treasury Department -
Global bond markets are getting hammered. Here’s why that could make your life more expensive -
‘Brazen act of self-dealing.’ Lawmakers, watchdogs alarmed after Trump regulators let Trump firm start a bank -
The S&P 500 is back at a record high and the Dow just hit 54,000
